Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #10514
Ace Report Cover Osteoarthritis

Noninferior improvement in function over 24 weeks with Structovial HA vs Hylan G-F 20 HA for knee OA

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.

Clin Exp Rheumatol. 2011 May-Jun;29(3):527-35

Contributing Authors: M Zaim T Trc F Berenbaum E Maheu T Appelboom S Jeka K Maasalu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


279 patients with Kellgren-Lawrence grade II-III knee osteoarthritis were randomized to three weekly intraarticular injections of either F60027 sodium hyaluronate (Structovial; Pierre Fabre) or Hylan G-F20 (Synvisc). The primary purpose of this study was to examine if F60027 was noninferior to Hylan G-F20 for functional improvement over 24-week follow-up. Mean improvement in Lequesne Index score f...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.